Bremelanotide PT 141 Men Erectile Dysfunction Randomized Trial: What the Evidence Shows Double blind, placebo controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT 141, a melanocortin receptor agonist, in healthy males and patients with mild to moderate erectile dysfunction Bremelanotide PT 141 Erectile Dysfunction Randomized Controlled Trial Men: Evidence and Practical Insights Baltimore PT141 Peptide Therapy for Erectile Dysfunction Dallas PT 141 Peptide Sexual Dysfunction Treatment PT 141 Nasal Spray vs Injection: Key Differences Explained